Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Definiens will present image analysis software at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago

Definiens , the number one Enterprise Image Intelligence company, will present its image analysis software for use in clinical trials and translational research at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, from June 4th to 8th. Definiens software enables personalized medicine by providing oncology researchers and drug developers with deeper insights into the underlying biology of cancer from the analysis of digital pathology and non-invasive medical images.

Definiens digital pathology image analysis software allows pathologists to accurately identify, quantify and interpret biomarkers and cellular morphology in tissue samples on a cell-by-cell basis. With Definiens Tissue Studio researchers have the ability to make earlier, more informed drug prioritization decisions by validating drug-target interaction as well as the measurement of surrogate biomarkers for toxicity. Additionally, Definiens Tissue Studio provides automated biomarker and morphological analysis for translational research in retrospective or prospective settings.

Definiens radiology software supports the volumetric analysis of lesions and organs over time. A recent study conducted with Merck & Co. demonstrated that volumetric insight, gained with Definiens software, can provide earlier indications of a candidate compound’s efficacy, potentially shortening clinical trials and providing substantial cost savings.

ASCO meeting attendees who would like to learn more about how Definiens software supports personalized medicine and translational research are invited to visit booth 13140.

Definiens in Digital Pathology and Medical Imaging
Definiens supports biopharmaceutical companies, clinical service organizations, and academic research institutions by automating image analysis on an enterprise level, from drug discovery to diagnostics. The company’s image analysis software enables the interpretation of vast numbers of digital images accurately and consistently. Definiens image analysis software for digital pathology and non-invasive medical images reveals biologically relevant insights for the advancement of translational research and personalized medicine. More information on Definiens’ digital pathology software is available at www.tissuestudio.com. For further information on Definiens radiology software, please visit www.definiens.com/lymphexpert.

Source: Definiens